The US biotech’s technology integrates multiple protein modalities to simultaneously target a variety of disease mechanisms.

During the quarter ended March 31, 2026, Baron Health Care Fund® (the Fund) declined 6.97% (Institutional Shares), compared ...

At the Hubbis Independent Wealth Management Forum - Singapore 2026, San Lo, Director, Intermediary Sales at Janus Henderson Investors, set out a case for reassessing China through a more selective, ...

Barry Sharpless and his team first popularised the concept of ‘clicking’ two molecules together back in 2001 – 25 years ago this month. The review paper that launched a new field has now been cited ...

The theory behind antibody drug conjugates (ADCs) is simple yet elegant: by combining the specificity of a monoclonal antibody with the cytotoxicity of a potent small molecule drug, ADCs can precisely ...

The conjugate space is evolving fast - moving beyond traditional ADCs into new formats like degrader-conjugates, oligonucleotide conjugates, bispecific ADCs, and more. The 4 th Novel Conjugates Summit ...

Antibody–drug conjugates have emerged as a powerful tool to deliver highly targeted cancer therapies. Next-generation antibody-drug conjugate designs aim to push the envelope even further.

Thomas J Catalano is a CFP and Registered Investment Adviser with the state of South Carolina, where he launched his own financial advisory firm in 2018. Thomas' experience gives him expertise in a ...

May 22, 2026 Scientists have uncovered a strange hidden structure formed during the creation of metallocenes, a class of sandwich-like molecules used in everything from catalysis to medicine. The ...